Skip to main content

Lumos Pharma, Inc.

LUMODelisted Dec 12, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001126234

Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.

13F holders, Q3 2021

Institutional positions in Lumos Pharma, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
37
−3 vs. Q2 2021
Shares held
2.87M
−336.6K (−10.5%) vs. Q2 2021
Total value
$27.3M
−$4.81M (−15.0%) vs. Q2 2021
New holders
4
7 more added
Sold out
7
9 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LUMO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 37 institutions
Q1 2021: 41 institutionsQ2 2021: 40 institutionsQ3 2021: 37 institutionsQ4 2021: 38 institutionsQ1 2022: 36 institutionsQ2 2022: 36 institutionsQ3 2022: 35 institutionsQ4 2022: 38 institutionsQ1 2023: 37 institutionsQ2 2023: 35 institutionsQ3 2023: 34 institutionsQ4 2023: 37 institutionsQ1 2024: 36 institutionsQ2 2024: 36 institutionsQ3 2024: 29 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2021: $27.3M
Q1 2021: $38.8MQ2 2021: $32.1MQ3 2021: $27.3MQ4 2021: $18.7MQ1 2022: $23.3MQ2 2022: $18.7MQ3 2022: $23.0MQ4 2022: $8.51MQ1 2023: $7.40MQ2 2023: $7.90MQ3 2023: $8.05MQ4 2023: $7.52MQ1 2024: $6.14MQ2 2024: $4.82MQ3 2024: $8.08MQ4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding LUMO and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 202429$8.08M
Q2 202436$4.82M
Q1 202436$6.14M
Q4 202337$7.52M
Q3 202334$8.05M
Q2 202335$7.90M
Q1 202337$7.40M
Q4 202238$8.51M
Q3 202235$23.0M
Q2 202236$18.7M
Q1 202236$23.3M
Q4 202138$18.7M
Q3 202137$27.3M
Q2 202140$32.1M
Q1 202141$38.8M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Lumos Pharma, Inc.; share changes are against Q2 2021.

Institutions holding LUMO in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
NEA Management Company, LLC526,663$5.01M0.06%00.0%Unchanged
Blackstone Group Inc.468,145$4.45M0.01%00.0%Unchanged
Lion Point Capital, LP407,192$3.87M1.03%00.0%Unchanged
Wells Fargo & Company317,185$3.02M0.00%+101,227+46.9%Added
Renaissance Technologies LLC286,412$2.72M0.00%−19,345−6.3%Reduced
Vanguard Group Inc239,029$2.27M0.00%+1,131+0.5%Added
Price T Rowe Associates Inc159,595$1.52M0.00%00.0%Unchanged
Jefferies Group LLC120,651$1.15M0.03%00.0%Unchanged
BlackRock Inc.60,857$579.0K0.00%−773−1.3%Reduced
Bridgeway Capital Management, LLC47,643$453.0K0.01%−4,900−9.3%Reduced
Investors Financial Group, LLC34,600$329.0K0.17%+5,000+16.9%Added
Minerva Advisors LLC34,015$321.0K0.19%+34,015New
Connor, Clark & Lunn Investment Management Ltd.33,427$318.0K0.00%+1,489+4.7%Added
Geode Capital Management, LLC28,356$269.0K0.00%+5,164+22.3%Added
Dimensional Fund Advisors LP20,953$199.0K0.00%−18,452−46.8%Reduced
Millennium Management LLC15,348$146.0K0.00%+15,348New
Marquette Asset Management, LLC13,234$126.0K0.03%+4,315+48.4%Added
Citadel Advisors LLC11,869$113.0K0.00%+11,869New
Wealth Advisors of Iowa, LLC11,760$112.0K0.06%00.0%Unchanged
Bank of New York Mellon Corp11,857$112.0K0.00%−4,104−25.7%Reduced
State Street Corp11,237$107.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,658$16.0K0.00%−738−30.8%Reduced
Northern Trust Corp1,008$10.0K0.00%−748−42.6%Reduced
Morgan Stanley1,133$10.0K0.00%00.0%Unchanged
West Financial Advisors, LLC784$7.00K0.00%00.0%Unchanged
Captrust Financial Advisors400$4.00K0.00%00.0%Unchanged
UBS Group AG473$4.00K0.00%+362+326.1%Added
Sphinx Trading, LP277$3.00K0.00%+277New
Royal Bank of Canada213$2.00K0.00%−38−15.1%Reduced
Proequities, Inc.89$1.00K0.00%00.0%Unchanged
Group One Trading, L.P.150$1.00K0.00%00.0%Unchanged
Eaton Vance Management58$1.00K0.00%00.0%Unchanged
Northwestern Mutual Wealth Management Co73$1.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1$00.00%−122−99.2%Reduced
Syverson Strege & Co22$00.00%00.0%Unchanged
Jacobi Capital Management LLC5$00.00%00.0%Unchanged
Global Retirement Partners, LLC11$00.00%00.0%Unchanged
Opaleye Management Inc.0$00.00%−382,000−100.0%Sold out
Paragon Associates & Paragon Associates II Joint Venture0$00.00%−50,000−100.0%Sold out
Deerfield Management Company, L.P. (Series C)0$00.00%−33,117−100.0%Sold out
Acadian Asset Management LLC0$00.00%−2,186−100.0%Sold out
Fifth Third Bancorp0$00.00%−111−100.0%Sold out
US Bancorp0$00.00%−111−100.0%Sold out
Bank of America Corp0$00.00%−19−100.0%Sold out